Science

Indian Point on the Potomac: Entergy's New Safety Panel and PR Firm

There's no question that New York's Indian Point nuclear power plant could use some public relations help. But Entergy, Indian Point's owner, might have chosen their new PR firm a little more carefully.

Last year, the state of New York asked the U.S. Nuclear Regulatory Commission (NRC) to deny the plant's license extension application, citing "a long and troubling history of problems." It was "the first time that a state had stepped forward to flatly oppose license renewals," according to the New York Times.

Then, in January, the NRC proposed a $650,000 fine against Indian Point, for having repeatedly missed deadlines to install a new emergency siren system. The fine is "10 times the normal size" of such sanctions, reported the Times.

To address such criticisms, Entergy has retained the Burson-Marsteller firm, funded the pro-nuclear "New York Affordable Reliable Electricity Alliance" and brought Greenpeace activist-turned-PR consultant Patrick Moore to New York. Last month, Entergy made another effort to, in their own words, "provide public assurances about the operation and protection of New York's largest nuclear power facility." They announced the formation of an "Independent Safety Evaluation" panel to investigate Indian Point.

Lavishing Doctors with Drug Money

Medicines Australia (MA), the peak drug industry lobby group, has unveiled details of how much its 42 member companies (and one non-member) spent in the last half of 2007 on each one of over 14,000 events that were designed to promote their drugs to doctors.

Imaging Study Leaves Tobacco Funding Out of the Picture

The lead author of the largest lung cancer screening study ever performed has come under fire for accepting cigarette company funding for the study. Dr.

Congress Discovers Independent Studies Ignored in Favor of Industry Findings

When the U.S. Food and Drug Administration determined that a particular chemical in plastic was not harmful, they used scientific studies to prove it.

Telling It Like It Is

The director of external relations for Procter & Gamble, Mark Chakravarty, recently told a UK healthcare PR conference that the drug industry is less than popular with the public. "There is a high suspicion of the pharma industry. Greed, dishonesty and fraud are some of its associations. The clinical trial press this week and an increased number of drug scandals add to this image," he said.

Introducing the coalSwarm

In the spring of 2007, when author Ted Nace set out to profile the emerging No New Coal Plants movement for Orion magazine, he had no idea that the assignment would turn into more than just a single article.

This Is Your Brain on Logos

Subliminal advertising may be "more effective than regular advertising, because people don't have time to raise their anti-ad defenses," according to a new study.

Global Warming Hurts Our Feelings

"A pair of agriculture groups has temporarily suspended about $1.5 million in grants to the University of Minnesota to protest a controversial study by U scientists earlier this month about biofuels and global warming," reports Tom Meersman.

Despite Congressional Direction and Funding, EPA Libraries Remain Closed

The Environmental Protection Agency began closing several of its libraries in 2006 due to a shrinking budget. But the agency did not take into account how access to important environmental data would be blocked for legislators, researchers and citizens.

No-Bid PR Contract Bugs California Officials

"State officials struggling to convince critics about the safety of aerial spraying to control an invasive moth awarded a $500,000 no-bid contract to a prominent public relations firm with ties to Gov. Arnold Schwarzenegger," reports Associated Press.

Syndicate content